全文获取类型
收费全文 | 102134篇 |
免费 | 7060篇 |
国内免费 | 2505篇 |
专业分类
耳鼻咽喉 | 527篇 |
儿科学 | 1363篇 |
妇产科学 | 1051篇 |
基础医学 | 6710篇 |
口腔科学 | 1471篇 |
临床医学 | 10475篇 |
内科学 | 8528篇 |
皮肤病学 | 800篇 |
神经病学 | 3755篇 |
特种医学 | 2109篇 |
外国民族医学 | 6篇 |
外科学 | 7412篇 |
综合类 | 23964篇 |
现状与发展 | 4篇 |
一般理论 | 43篇 |
预防医学 | 21505篇 |
眼科学 | 1224篇 |
药学 | 7645篇 |
449篇 | |
中国医学 | 10442篇 |
肿瘤学 | 2216篇 |
出版年
2024年 | 310篇 |
2023年 | 1633篇 |
2022年 | 3076篇 |
2021年 | 4114篇 |
2020年 | 4321篇 |
2019年 | 3617篇 |
2018年 | 3233篇 |
2017年 | 3154篇 |
2016年 | 3033篇 |
2015年 | 2804篇 |
2014年 | 6974篇 |
2013年 | 6696篇 |
2012年 | 6443篇 |
2011年 | 7597篇 |
2010年 | 6676篇 |
2009年 | 5296篇 |
2008年 | 5274篇 |
2007年 | 5314篇 |
2006年 | 4777篇 |
2005年 | 3909篇 |
2004年 | 3105篇 |
2003年 | 2680篇 |
2002年 | 1926篇 |
2001年 | 1685篇 |
2000年 | 1409篇 |
1999年 | 1180篇 |
1998年 | 950篇 |
1997年 | 891篇 |
1996年 | 737篇 |
1995年 | 749篇 |
1994年 | 646篇 |
1993年 | 455篇 |
1992年 | 452篇 |
1991年 | 452篇 |
1990年 | 383篇 |
1989年 | 361篇 |
1988年 | 366篇 |
1987年 | 294篇 |
1986年 | 320篇 |
1985年 | 520篇 |
1984年 | 512篇 |
1983年 | 410篇 |
1982年 | 445篇 |
1981年 | 417篇 |
1980年 | 418篇 |
1979年 | 339篇 |
1978年 | 328篇 |
1977年 | 303篇 |
1976年 | 242篇 |
1975年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 系统评价翻转课堂教学模式在物理治疗学教学中的应用效果。方法 计算机检索CENTRAL、MEDLINE、EMBASE、CINAHL Plus、Academic Search Premier、Teacher Reference Center、ERIC以及Education Research,纳入翻转课堂教学模式应用于物理治疗学教学的原始研究。检索时限为建库至2021年6月。由2名研究人员独立完成文献筛选、数据提取、质量评价,对翻转课堂教学模式对比传统教学模式在物理治疗学教学中的效果进行综述。结果与结论 共检索文献1 307篇,最终纳入7篇,包括至少770名学生。发表时间集中在2013年至2019年,研究对象为物理治疗学专业学生,主要结局指标为考试成绩。翻转课堂教学模式总体说来可提高学生的笔试成绩,增强高阶思维能力,得到了学生和教师的积极评价。 相似文献
3.
4.
5.
The Postoperative Short Course Content Study group 《Anaesthesia》2022,77(5):570-579
Most surgical and anaesthetic mortality and morbidity occurs postoperatively, disproportionately affecting low- and middle-income countries. Various short courses have been developed to improve patient outcomes in low- and middle-income countries, but none specifically to address postoperative care and complications. We aimed to identify key features of a proposed short-course addressing this topic using a Delphi process with low- and middle-income country anaesthesia providers trained as short-course facilitators. An initial questionnaire was co-developed from literature review and exploratory workshops to include 108 potential course features. Features included content; teaching method; appropriate participants; and appropriate faculty. Over three Delphi rounds (panellists numbered 86, 64 and 35 in successive cycles), panellists indicated which features they considered most important. Responses were analysed by geographical regions: Africa, the Americas, south-east Asia and Western Pacific. Ultimately, panellists identified 60, 40 and 54 core features for the proposed course in each region, respectively. There were high levels of consensus within regions on what constituted core course content, but not between regions. All panellists preferred the small group workshop teaching method irrespective of region. All regions considered anaesthetists to be key facilitators, while all agreed that both anaesthetists and operating theatre nurses were key participants. The African and Americas regional panels recommended more multidisciplinary healthcare professionals for participant roles. Faculty from high-income countries were not considered high priority. Our study highlights variability between geographical regions as to which course features were perceived as most locally relevant, supporting regional adaptation of short-course design rather than a one-size-fits-all model. 相似文献
6.
7.
8.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
9.
采用文献复习和实证研究经验的方法对《医疗质量管理办法》中涉及的医疗质量概念及相关问题进行探讨。《医疗质量管理办法》中的医疗质量的定义存在重大缺失,没有涉及医疗服务的结果,特别是患者安全。医疗质量的定义应与国际相关权威机构保持一致,应高度重视医疗服务的结果,特别是患者安全。 相似文献
10.
《Journal of vascular and interventional radiology : JVIR》2022,33(6):660-667
PurposeTo investigate the safety and efficacy of an aqueous polyethylene glycol-based liquid embolic agent, Embrace Hydrogel Embolic System (HES), in the treatment of benign and malignant hypervascular tumors.Materials and MethodsA prospective, single-arm, multicenter study included 8 patients, 5 males and 3 females, with a median age of 58.5 years (30–85 years), who underwent embolization in 8 tumors between October 2019 and May 2020. Technical success was defined as successful delivery of HES to the index vessel, with disappearance of >90% of the targeted vascular enhancement or, for portal vein embolization, occlusion of the portal branches to the liver segments for future resection. The volume of HES administered, ease of use (5 point Likert scale), administration time, and adverse events (AEs) were recorded. Evaluation was performed at 7, 30, and 90 days via clinical assessment and blood testing, and follow-up imaging was performed at 30 days.ResultsEight patients were enrolled, and 10 embolizations were performed in 8 lesions. Tumors included hepatocellular carcinoma (n = 4), renal angiomyolipoma (n = 3), and intrahepatic cholangiocarcinoma (n = 1). Technical success was 100%, and the average ease of use was 3.3 ± 1.0 SD. The HES delivery time was 1–28 minutes (median, 16.5 minutes), and the HES volume injected was 0.4–4.0 mL (median, 1.3 mL). All patients reached 30-day follow-up with imaging, and 6 patients reached 90-day follow-up. There were 3 serious AEs in 2 patients that were unrelated to the embolic agent.ConclusionHES resulted in a 100% embolization technical success rate. The product ease of use was acceptable, and no target vessel recanalization was noted on follow-up imaging at 30 days. 相似文献